RXRB, or Retinoid X Receptor Beta, is a member of the nuclear receptor superfamily, specifically belonging to the Retinoid X Receptor (RXR) subfamily alongside RXRA and RXRG. As a ligand-dependent transcription factor, RXRB functions by binding to specific ligands, such as 9-cis-retinoic acid, to form either homodimers or heterodimers with other nuclear receptors, including the vitamin D receptor and thyroid hormone receptor. These receptor complexes bind to hormone response elements (HREs) within the regulatory regions of target genes, thereby modulating their transcriptional activity. This mechanism is central to the regulation of lipid metabolism, glucose homeostasis, inflammatory responses, and cellular differentiation, with RXRB playing a particularly significant role in the PPARα pathway governing fatty acid oxidation. The gene is predominantly expressed in metabolically active tissues, including the liver, kidneys, adipose tissue, and the immune system. Dysregulation of RXRB function, whether through loss-of-function or gain-of-function mutations that impair dimerization or ligand binding, is implicated in various pathological conditions, including metabolic syndrome, diabetes, and certain cancers such as thyroid carcinoma. While overexpression of RXRB can enhance lipolysis and improve insulin sensitivity, excessive activation may paradoxically trigger apoptosis or autoimmune reactions, whereas reduced expression is associated with adiposity, chronic inflammation, and exacerbated metabolic disorders. The RXR family's ability to form diverse dimeric combinations allows for a broad regulatory scope, underscoring its critical role in both developmental processes and metabolic homeostasis.
Subcellular localization of RXRB (and its protein):
Gene Ontology (GO) terms for RXRB:
| Interacting Gene | Interaction | Source/Score |
| Name |
|---|
| 4920 Adipocytokine signaling pathway [PATH:hsa04920] |
| 3320 PPAR signaling pathway [PATH:hsa03320] |
| 4919 Thyroid hormone signaling pathway [PATH:hsa04919] |
| 5200 Pathways in cancer [PATH:hsa05200] |
| 5202 Transcriptional misregulation in cancers [PATH:hsa05202] |
| 5216 Thyroid cancer [PATH:hsa05216] |
| 5222 Small cell lung cancer [PATH:hsa05222] |
| 5223 Non-small cell lung cancer [PATH:hsa05223] |
| Name |
|---|
| Gene Expression |
| Generic Transcription Pathway |
| Nuclear Receptor transcription pathway |
| Signaling by Retinoic Acid |
| Disease | Score | NofPmids | NofSnps | Source |
| Mammary Neoplasms | 0.12 | 1 | 0 | CTD_human |
| Disease Progression | 0.12 | 1 | 0 | CTD_human |
| Stomach Neoplasms | 0.12 | 1 | 0 | CTD_human |
| Prostatic Neoplasms | 0.00272435 | 1 | 0 | LHGDN |
| Lung Neoplasms | 0.00272435 | 1 | 0 | LHGDN |
| Diabetes Mellitus, Insulin-Dependent | 0.002638474 | 1 | 0 | BeFree_GAD |
| Schizophrenia | 0.002638474 | 1 | 0 | BeFree_GAD |
| Spontaneous abortion | 0.002367032 | 1 | 0 | GAD |
| Chronic Obstructive Airway Disease | 0.002367032 | 1 | 0 | GAD |
| Psoriasis | 0.002367032 | 1 | 0 | GAD |
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: [email protected]